IMMULITE 2000 ANDROSTENEDIONE L2KAO

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2014-01-14 for IMMULITE 2000 ANDROSTENEDIONE L2KAO manufactured by Siemens Healthcare Diagnostics Inc..

Event Text Entries

[4037021] The customer has observed high bias on biorad quality control sample level 2 and patient samples for the androstenedione assay on an immulite 2000 instrument when using reagent lot 314 and 316. It is unknown if patient results were reported to the physician(s). There were no known reports of patient intervention or adverse health consequences due to the high bias observed on biorad quality control sample level 2 and patient samples when using reagent lot 314 and 316.
Patient Sequence No: 1, Text Type: D, B5


[11559803] Siemens has investigated the incidence of over recovery of patient samples and quality controls on the immulite/immulite1000 androstenedione assay lot number 409 and above, and immulite 2000/immulite 2000 xpi androstenedione assay lot number 314 and above. Siemens has confirmed that these lots are linear up to a concentration of 5. 5 ng/ml, instead of the 10 ng/ml as stated in the instructions for use (ifu). Quality control materials at concentrations between 5. 5 ng/ml and 10 ng/ml will detect this issue. An urgent medical device correction (umdc) 2013-12-19 was sent to us customers and an urgent field safety notice (ufsn) 4008 was sent to ous customers in december of 2013. The umdc and ufsn state that customers are requested to use quality control materials with at least two levels having concentrations less than 5. 5 ng/ml, and that patient values >5. 5 ng/ml should be verified using an alternate method.
Patient Sequence No: 1, Text Type: N, H10


[32155292] The original mdr 2432235-2014-00126 was filed on january 14, 2014. Additional information (5/27/14): the over recovery and loss of linearity of the immulite systems androstenedione assay has been identified to be variability of a critical raw material (variation in the activity of rma160 alkaline phosphatase (unlabeled/low activity alkaline phosphatase, cold ap) in the reagent wedge). In addition, siemens healthcare sent out a customer bulletin 2014-05 in may 2014, announcing the restoration of the linearity of the androstenedione assay on the immulite 2000/immulite 2000 xpi to 10 ng/ml (35 nml/l), beginning with kit lot 331.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2432235-2014-00126
MDR Report Key3574956
Report Source01,05,06
Date Received2014-01-14
Date of Report2013-12-18
Date of Event2013-09-19
Date Mfgr Received2014-05-27
Date Added to Maude2014-04-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactMS. ELIZABETH BEATO
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145243074
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS(REG#3002806944)
Manufacturer StreetGLYN RHOWNY LLANBERIS, CAERNARFON
Manufacturer CityGWYNEDD, WALES LL54EL
Manufacturer CountryUK
Manufacturer Postal CodeLL5 4EL
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction Number2432235-01/02/14-001-C
Event Type3
Type of Report3

Device Details

Brand NameIMMULITE 2000 ANDROSTENEDIONE
Generic NameIMMULITE 2000 ANDROSTENEDIONE
Product CodeCIZ
Date Received2014-01-14
Model NumberIMMULITE 2000 ANDROSTENEDIONE
Catalog NumberL2KAO
Lot Number314, 316
OperatorOTHER HEALTH CARE PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS INC.
Manufacturer AddressGLYN RHONWY LLANBERIS, CAERNARFON, GWYNEDD, WALES LL554EL UK LL55 4EL


Patients

Patient NumberTreatmentOutcomeDate
10 2014-01-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.